The Utrecht bleeding risk score can be used to assess the risk of major bleeding in medical patients being treated with heparin or low molecular weight heparin for acute venous thromboembolism.
Parameters:
(1) WHO performance status (same as ECOG)
(2) history of bleeding
(3) history of recent trauma or surgery
(4) body surface area in square meters
Parameter |
Finding |
Points |
WHO performance status |
WHO grade 0 or 1 |
0 |
|
WHO grade 2 |
1 |
|
WHO grade 3 or 4 |
2 |
history of bleeding |
absent |
0 |
|
present |
2 |
recent trauma or surgery (< 2 months) |
absent |
0 |
|
present |
1 |
body surface area |
< 1.7 square meters |
2 |
|
1.7 to 2.0 square meters |
1 |
|
> 2 square meters |
0 |
where:
• The WHO performance status is the same as the ECOG scale.
• The body surface area is calculated using Mosteller's equation
body surface area in meter squared =
= square root ((height in cm) * (weight in kg) /3600))
Utrecht bleeding risk score =
= (points for WHO performance status) + (points for bleeding history) + (points for recent trauma) + (points for body surface area)
Interpretation:
• minimum score 0
• maximum score 7
• low risk for bleeding: <= 2 points
• middle risk for bleeding: 3 or 4 points
• high risk for bleeding: >= 5 points
Limitations:
• The score is not useful to identify patients at risk of minor bleeding.
Purpose: To use the Utrecht bleeding risk score to predict the risk of bleeding in a medical patient being treated with heparin.
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical
Objective: risk factors, severity, prognosis, stage
ICD-10: I80, I81, I82,